224 related articles for article (PubMed ID: 17187164)
1. Different hemodynamic responses by color Doppler ultrasonography studies between sildenafil non-responders and responders.
Huang ST; Hsieh ML
Asian J Androl; 2007 Jan; 9(1):129-33. PubMed ID: 17187164
[TBL] [Abstract][Full Text] [Related]
2. A new method for the evaluation of erectile dysfunction: sildenafil plus Doppler ultrasonography.
Arslan D; Esen AA; Seçil M; Aslan G; Celebi I; Dicle O
J Urol; 2001 Jul; 166(1):181-4. PubMed ID: 11435852
[TBL] [Abstract][Full Text] [Related]
3. The value of sildenafil as mode of stimulation in pharmaco-penile duplex ultrasonography.
Speel TG; Bleumer I; Diemont WL; van der Maas MC; Wijkstra H; Meuleman EJ
Int J Impot Res; 2001 Aug; 13(4):189-91. PubMed ID: 11494073
[TBL] [Abstract][Full Text] [Related]
4. Efficacies of papaverine and sildenafil in the treatment of erectile dysfunction in early-stage paraplegic men.
Yildiz N; Gokkaya NK; Koseoglu F; Gokkaya S; Comert D
Int J Rehabil Res; 2011 Mar; 34(1):44-52. PubMed ID: 20700057
[TBL] [Abstract][Full Text] [Related]
5. Long-term intracavernous therapy responders can potentially switch to sildenafil citrate after radical prostatectomy.
Raina R; Lakin MM; Agarwal A; Ausmundson S; Montague DK; Zippe CD
Urology; 2004 Mar; 63(3):532-7; discussion 538. PubMed ID: 15028452
[TBL] [Abstract][Full Text] [Related]
6. [Color-Doppler ultrasonography in the diagnostic evaluation of erectile dysfunction].
Junuzović D; Mehmedbasić S; Smajlović F
Med Arh; 2003; 57(5-6):279-83. PubMed ID: 15022579
[TBL] [Abstract][Full Text] [Related]
7. Sildenafil citrate vs intracavernous alprostadil for patients with arteriogenic erectile dysfunction: a randomised placebo controlled study.
Mancini M; Raina R; Agarwal A; Nerva F; Colpi GM
Int J Impot Res; 2004 Feb; 16(1):8-12. PubMed ID: 14963465
[TBL] [Abstract][Full Text] [Related]
8. Sildenafil non-responders: haemodynamic and morphometric studies.
Wespes E; Rammal A; Garbar C
Eur Urol; 2005 Jul; 48(1):136-9; discussion 139. PubMed ID: 15967263
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of a progressive treatment program for erectile dysfunction in patients with diabetes mellitus.
Israilov S; Shmuely J; Niv E; Engelstein D; Livne P; Boniel J
Int J Impot Res; 2005; 17(5):431-6. PubMed ID: 15889124
[TBL] [Abstract][Full Text] [Related]
10. Switching from intracavernous prostaglandin E1 injections to oral sildenafil citrate in patients with erectile dysfunction: results of a multicenter European study. The Sildenafil Multicenter Study Group.
Giuliano F; Montorsi F; Mirone V; Rossi D; Sweeney M
J Urol; 2000 Sep; 164(3 Pt 1):708-11. PubMed ID: 10953130
[TBL] [Abstract][Full Text] [Related]
11. The role of endothelial dysfunction in the pathophysiology of erectile dysfunction in diabetes and in determining response to treatment.
Pegge NC; Twomey AM; Vaughton K; Gravenor MB; Ramsey MW; Price DE
Diabet Med; 2006 Aug; 23(8):873-8. PubMed ID: 16911625
[TBL] [Abstract][Full Text] [Related]
12. Effectiveness of vardenafil versus papaverine in penile Doppler ultrasonography.
Ardicoglu A; Kocakoc E; Tuygun UO; Bozgeyik Z; Orhan I
Urol Int; 2005; 75(1):75-9. PubMed ID: 16037713
[TBL] [Abstract][Full Text] [Related]
13. Comparison of satisfaction rates and erectile function in patients treated with sildenafil, intracavernous prostaglandin E1 and penile implant surgery for erectile dysfunction in urology practice.
Rajpurkar A; Dhabuwala CB
J Urol; 2003 Jul; 170(1):159-63. PubMed ID: 12796670
[TBL] [Abstract][Full Text] [Related]
14. A classification based on peak systolic velocity and end diastolic velocity predicts sildenafil citrate success.
Murad Basar M; Atan A; Tekdogan UY; Batislam E
Scand J Urol Nephrol; 2003; 37(6):502-6. PubMed ID: 14675925
[TBL] [Abstract][Full Text] [Related]
15. Intracavernous injections for erectile dysfunction in patients with cardiovascular diseases and failure or contraindications for sildenafil citrate.
Israilov S; Niv E; Livne PM; Shmueli J; Engelstein D; Segenreich E; Baniel J
Int J Impot Res; 2002 Feb; 14(1):38-43. PubMed ID: 11896476
[TBL] [Abstract][Full Text] [Related]
16. Is sildenafil citrate an alternative agent in the evaluation of penile vascular system with color Doppler ultrasound?
Erdoğru T; Usta MF; Ceken K; Köksal T; Ates M; Kabaalioğlu A; Baykara M
Urol Int; 2002; 68(4):255-60. PubMed ID: 12053028
[TBL] [Abstract][Full Text] [Related]
17. Feasability of a novel audio-video sexual stimulation system: an adjunct to the use of penile duplex Doppler ultrasonography for the investigation of erectile dysfunction.
Kuo YC; Liu SP; Chen JH; Chang HC; Tsai VF; Hsieh JT
J Sex Med; 2010 Dec; 7(12):3979-83. PubMed ID: 19912490
[TBL] [Abstract][Full Text] [Related]
18. Clinical and duplex US assessment of effects of sildenafil on cavernosal arteries of the penis: comparison with intracavernosal injection of vasoactive agents--initial experience.
Copel L; Katz R; Blachar A; Sosna J; Sheiman RG
Radiology; 2005 Dec; 237(3):986-91. PubMed ID: 16237136
[TBL] [Abstract][Full Text] [Related]
19. Sildenafil citrate for penile hemodynamic determination: an alternative to intracavernosal agents in Doppler ultrasound evaluation of erectile dysfunction.
Baçar MM; Batislam E; Altinok D; Yilmaz E; Baçar H
Urology; 2001 Apr; 57(4):623-6; discussion 626-7. PubMed ID: 11306361
[TBL] [Abstract][Full Text] [Related]
20. Improved spontaneous erectile function in men with mild-to-moderate arteriogenic erectile dysfunction treated with a nightly dose of sildenafil for one year: a randomized trial.
Sommer F; Klotz T; Engelmann U
Asian J Androl; 2007 Jan; 9(1):134-41. PubMed ID: 17187165
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
